Diseases of iron metabolism

Pediatric Clinics of North America

Volumn 49, Issue 5, 2002, Pages 893-909

  Hagar, Ward ^a   Theil, Elizabeth C ^b   Vichinsky, Elliott P ^a  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON;

ADRENAL GLAND; ANEMIA; CEREBELLUM; CHRONIC INFLAMMATION; CONGENITAL CATARACT; DISEASE MARKER; DISEASE SEVERITY; FERRITIN BLOOD LEVEL; FRIEDREICH ATAXIA; HALLERVORDEN SPATZ DISEASE; HEART; HEMOCHROMATOSIS; HYPERFERRITINEMIA; IRON BLOOD LEVEL; IRON METABOLISM; IRON OVERLOAD; KIDNEY; LIVER; METABOLIC DISORDER; PANCREAS; PEARSON SYNDROME; REVIEW; SIDEROBLASTIC ANEMIA;

HUMANS; IRON METABOLISM DISORDERS;

EID: 0036774472     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(02)00028-7     Document Type: Review

References (78)

1. Seth S, Brittenham GM. Genetic disorders affecting proteins of iron metabolism: Clinical implications. Annu Rev Med 2000;51:443-64.
2. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999;341:1986-95.
3. Harford JB, Rouualt TA, Klausner RD. The control of cellular iron homeostasis. In Brock JH, Halliderg JW, Pippard JM, Powell LW, et al, editors. Iron Metabolism in Health and Disease. London: W.B. Saunders Company; 1994. p. 123-149.
4. Rao KR, Patel AR, Honig GR, et al. Iron deficiency and sickle cell anemia. Arch Intern Med 1983;143:1030-2.
5. Vichinsky E, Kleman K, Embury S, et al. The diagnosis of iron deficiency anemia in sickle cell disease. Blood 1981;58:963-8.
6. Bottomley SS. Secondary iron overload disorders. Semin Hematol 1998;35:77-86.
7. Gordeuk VR, McLauren CE, MacPhail AP. Association of iron overload in Africa with hepatocellular carcinoma and tuberculosis: Strachan's 1929 Thesis Revisited. Blood 1996;87: 3470-6.
8. Harmatz P, Butensky E, Quirolo K, et al. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood 2000;96:76-9.
9. Olivieri NE, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood 1997;89:739-61.
10. Fahmy M, Young SP. Modulation of Iron Metabolism in Monocyte Cell Line U937 by Inflammatory Cytokines: Changes in Transferrin Uptake, Iron Handling and Ferritin mRNA 1993;296(Pt 1): 175-81.
11. Fillet G, Beguin Y, Baldelli L. Model of reticuloendothelial iron metabolism in humans: Abnormal behavior in idiopathic hemochromatosis and in inflammation. Blood 1989;74:844-51.
12. Peterson CM, Graziano JH, de Crutus A. Iron metabolism, sickle cell disease, and response to cyanate. Blood 1975;46:583-90.
13. Theil EC. Embryonic erythropoiesis and iron metabolism. Br J Haematol 1980;45:357-60.
14. Leggett BA, Fletcher LM, Ramm GA. Differential regulation of ferritin H and L subunit mRNA during inflammation and long-term iron overload. J Gastroenterol Hepatol 1993;8:21-7.
15. McCord JM. Iron, free radicals, and oxidative injury. Semin Hematol 1998;35:5-12.
16. Theil EC. Targeting mRNA to regulate iron and oxygen metabolism. Biochem Pharmacol 2000;59:87-93.
17. Chiueh CC. Iron Overload, Oxidative Stress, and Axonal Dystrophy in Brain Disorders. Pediatr Neurol 2001;25:138-47.
18. Theil EC. The ferritin family of iron storage proteins. Adv Enzymol Relat Areas Mol Biol 1990; 63:421-49.
19. Valentine JS. Redox and electrochemistry in biology. In: Theil EC, editor. Principles of Chemistry in Biology. Washington, DC: American Chemical Society; 1998. p. 137-55.
20. Brock JH, et al, editor. Iron Metabolism in Health and Disease. London: WB Saunders Company; 1994.
21. Theil EC. Ferritin: Structure, gene regulation, and cellular function in animals, plants, and microorganisms. Annu Rev Biochem 1987;56:289-315.
22. Brown JE, Theil EC. Red cells, ferritin, and iron storage during amphibian development. J Biol Chem 1978;253:2673-8.
23. Ferreira C, Santambrogio P, Martin ME. H ferritin knockout mice: A model of hyperferritinemia in the absence of iron overload. Blood 2001;98:525-32.
24. Roy CN, Enns CA. Iron homeostasis: New tales from the crypt. Blood 2000;96:4020-7.
25. Allikmets R, Raskind WH, Hutchinson A. Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Mol Genet 1999;8: 743-9.
26. Levi S, Corsi B, Bosisio M, et al. A human mitochondrial ferritin encoded by an intronless gene. J Biol Chem 2001;270:24437-40.
27. Cossee M, Puccio H, Gansmuller A, et al. Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum Mol Genet 2000;9: 1219-26.
28. Andrews NC. Iron metabolism: Iron deficiency and iron overload. Ann Rev Genom and Hum Genet 2000;1:75-98.
29. Brittenham GM. Clinical consequences of new insights in the pathophysiology of disorders of iron and heme metabolism, in American Society of Hematology Education Book 2000. In: Schechter GP, Berliner N, Telen MJ, editors. San Fransisco: American Society of Hematology; 2000. p. 39-42.
30. Yeh KY, Yeh M, Watkins JA, et al. Dietary iron induces rapid changes in rat intestinal divalent metal transporter expression. Am J Physiol Gastrointest Liver Physiol 2000;279:G1070-9.
31. Gross CN, Irrinki A, Feder JN, et al. Co-trafficking of HFE, a nonclassical major histocompatibility complex class I protein, with the transferrin receptor implies a role in intracellular iron regulation. J Biol Chem 1998;273:22068-74.
32. Ferreira C, Bucchini D, Martin ME, et al. Early embryonic lethality of H ferritin gene deletion in mice. J Biol Chem 2000;275:3021-4.
33. Theil EC. The IRE (iron regulatory element) family: Structures which regulate mRNA translation or stability. Biofactors 1993;4:87-93.
34. Festa M, Ricciardelli G, Mele G. Overexpression of H ferritin and up-regulation of iron regulatory protein genes during differentiation of 3T3-L1 pre-adipocytes. J Biol Chem 2000;275: 36708-12.
35. Cairo G, Pietrangelo A. Iron regulatory proteins in pathobiology. Biochem J 2000;352:241-50.
36. Theil EC, Eisenstein RS. Combinatorial mRNA regulation: Iron regulatory proteins and iso-iron-responsive elements (Iso-IREs). J Biol Chem 2000;275:40659-62.
37. Weiss G, Bogdan C, Hentze MW. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J Immunol 1997;158:420-5.
38. Theil EC. Iron regulatory elements (IREs): A family of mRNA non-coding sequences. Biochem J 1994;304:1-11.
39. Jin W, Takagi H, Pancorbo B, et al. "Opening" the ferritin pore for iron release by mutation of conserved amino acids at interhelix and loop sites. Biochemistry 2001;40:7525-32.
40. Takagi H, Shi D, Ha Y, et al. Localized unfolding at the junction of three ferritin subunits. A mechanism for iron release? J Biol Chem 1998;273:18685-8.
41. Theil EC, et al. The ferritin iron entry and exit problem. Inorganica Chimica Acta 2000; 297:242-51.
42. Puccio H, Koenig M. Recent advances in the molecular pathogenesis of Friedreich ataxia. Hum Mol Genet 2000;9:887-92.
43. McDonnell SM, Hover A, Gloe D, et al. Population-based Screening for Hemochromatosis Using Phenotypic and DNA Testing among Employees of Health Maintenance Organizations in Springfield, Missouri. Am J Med 1999;107:30-7.
44. Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromatosis: Evolution of diagnostic criteria. Gastroenterology 1998;114:319-23.
45. Bacon BR, Olynyk JK, Brunt EM, et al. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 1999;130:953-62.
46. Barton JC, McDonnell SM, Adams PC. Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med 1998;129:932-9.
47. Edward CQ, Griffen LM, Ajioka RS, et al. Screening for hemochromatosis: Phenotype vs genotype. Semin Hematol 1998;35:72-6.
48. Enns CA. Pumping iron: The strange partnership of the hemochromatosis protein, a class I MHC homolog, with the transferrin receptor. Traffic 2001;2:167-74.
49. Parkkila S, Waheed A, Britton RS, et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 1997; 94:13198-202.
50. Feder JN, Tsuchihashi Z, Irrinki A. The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem 1997;272: 14025-8.
51. Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 1998;95: 1472-7.
52. Montosi G, Donovan A, Totaro A, et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. [see comments] J Clin Invest 2001;108:619-23.
53. Knisely AS. Neonatal hemochromatosis. Adv Pediatr 1992;39:383-403.
54. Sigurdsson L, Reyes J, Kocoshis SA, et al. Neonatal hemochromatosis: Outcomes of pharmacologic and surgical therapies. J Pediatr Gastroenterol Nutr 1998;26:85-9.
55. Burton BK. Inborn errors of metabolism in infancy: A guide to diagnosis. Pediatrics 1998; 102:1471.
56. Marti-Bonmati L, Baamonde A, Poyatos CR. Prenatal diagnosis of idiopathic neonatal hemochromatosis with MR1. Abdom Imaging 1994;19:55-6.
57. Roetto A, Totaro A, Cazzola M, et al. Juvenile hemochromatosis locus maps to chromosome Iq. Am J Hum Genet 1999;64:1388-93.
58. Zoler ML. Hemochromatosis equally hits African Americans. Internal Medicine News 2001; 34(20):1.
59. Baer D. Hereditary iron overload and African Americans. [letter; comment] Am J Med 1996; 101:5-8.
60. Kato J, Fujikawa K, Kanda M, et al. A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet 2001;69:191-7.
61. Raskind WH, Wijsman E, Pagon RA, et al. X-linked sideroblastic anemia and ataxia: Linkage to phosphoglycerate kinase at Xq 13. Am J Hum Genet 1991;48:335-41.
62. Pearson HA, Lobel JS, Kocoshis SA, et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 1979;95: 976-84.
63. Rotig A, Cormier V, Blanche S, et al. Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest 1990;86:1601-8.
64. Connor JR, Menzies SL, Burdo JR. Iron and iron management proteins in neurobiology. Pediatr Neurol 2001;25:118-29.
65. LaVaute T, Smith S, Cooperman S, et al. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet 2001;27:209-14.
66. Puccio H, Simon D, Cossee M, et al. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 2001;27:181-6.
67. Curtis AR, Fey C, Morris CM, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. [see comments] Nat Genet 2001;28:350-4.
68. Radisky DC, Babcock MC, Kaplan J. The yeast frataxin homologue mediates mitochondrial iron efflux. Evidence for a mitochondrial iron cycle. J Biol Chem 1999;274:4497-9.
69. Victor M, Ropper AH, editors. Adams and Victor's Principles of Neurology. New York: McGraw-Hill; 2001. p. 1029-31.
70. Zhou B, Westaway SK, Levinson B, et al. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. [see comments] Nat Genet 2001;28:345-9.
71. Goya N, Miyazaki S, Kodate S, et al. A Family of Congenital Atransferrinemia. Blood 1972; 40:239-45.
72. Hayashi A, Wada Y, Suzuki T, et al. Studies on Familial Hypotransferrinemia: Unique Clinical Course and Molecular Pathology. Am J Hum Genet 1993;53:201-13.
73. Yoshida K, Furihata K, Takeda S, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 1995;9:267-72.
74. Miyajima H, Takahashi Y, Kamata T, et al. Use of desferrioxamine in the treatment of aceruloplasminemia. Ann Neurol 1997;41:404-7.
75. Cazzola M, Bergamaschi G, Tonon L, et al. Hereditary hyperferritinemia-cataract syndrome: Relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNA. [see comments] Blood 1997;90:814-21.
76. Camaschella C, Zecchina G, Lockitch G, et al. A new mutation (G51C) in the iron-responsive element (IRE) of L-ferritin associated with hyperferritinaemia-cataract syndrome decreases the binding affinity of the mutated IRE for iron-regulatory proteins. Br J Haematol 2000;108:480-2.
77. Allerson CR, Cazzola M, Rouault TA. Clinical severity and thermodynamic effects of iron-responsive element mutations in hereditary hyperferritinemia-cataract syndrome. J Biol Chem 1999;274:26439-47.
78. Orino K, Lehman L, Tsuji Y, et al. Ferritin and the response to oxidative stress. Biochem J 2001;357:241-7.